Weekly Recap | Novo Nordisk AS -7.58%, most brokers rate it holdWeekly Review·Sep 12 at 06:27 AMNVO-2.12%NVOX-4.44%
Weekly Recap | Novo Nordisk AS +2.17%, Wegovy pill launch in GermanyWeekly Review·Sep 5 at 07:34 AMNVO-2.12%NVOX-4.44%
Weekly Recap | Novo Nordisk AS -2.42%, oral Wegovy accepted for China reviewWeekly Review·Aug 29 at 06:07 AMNVO-2.12%NVOX-4.44%
Weekly Recap | NVO.US +1.85%, kicks off new oral obesity pill studyWeekly Review·Aug 22 at 05:32 AMNVO-2.12%NVOX-4.44%
